Additionally, inactivating mutations in receptor genes including TGF-βR1, TGF-βR2, and TGF-β superfamily members Activin Receptor type 2 (ACVR2) are reported in CRC [100]. This evidence concerns the gene TGFBR2 and colorectal carcinoma.